Navigation Links
Neurologix Announces First Quarter 2011 Financial Results
Date:5/13/2011

arges of $0.8 million, or $0.03 per basic and diluted share, related to preferred stock dividends in connection with the Series D Stock and the Series C Stock.

The Company had cash and cash equivalents of approximately $5.4 million as of March 31, 2011.

Clark A. Johnson, President and Chief Executive Officer of Neurologix, noted that these first quarter financial results were consistent with the Company's expectations. "During the first quarter, our leadership in gene therapy was strongly confirmed by the publication in The Lancet Neurology of the positive results of our Phase 2 clinical trial of gene transfer for the treatment of advanced Parkinson's disease. These are the first successful Phase 2 gene therapy results in any therapeutic area that have been published in a peer-reviewed journal. As we have reported before, we are continuing on the path to develop NLX-P101, our Parkinson's disease gene transfer therapy, as a much needed therapy for patients with Parkinson's disease and plan to submit a Phase 3 protocol to the FDA later this year."

About NeurologixNeurologix, Inc. (OTCBB:NRGX) is a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of life-altering gene transfer therapies for serious disorders of the brain and central nervous system. Neurologix's therapeutic approach is built upon the groundbreaking research of its scientific founders and advisors, whose accomplishments have formed the foundation of gene therapy for neurological illnesses. The Company's current programs address such conditions as Parkinson's disease, epilepsy, depression and Huntington's disease, all of which are large markets not adequately served by current therapeutic options. For more information, please visit the Neurologix website at http://www.neurologix.net.

Cautionary Statement Regarding Forward-Looking StatementsThis news release include
'/>"/>

SOURCE Neurologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Details Presented at the World Parkinson Congress on Neurologixs Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease
2. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
3. Neurologix Reports Third Quarter 2010 Financial Results
4. Neurologix Completes Additional $7 Million Financing
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014 Patient engagement has become ... organizations are turning to an assortment of marketing ... part of this evolving approach to patient engagement, ... and engage patients throughout their experiences with a ... By mapping the patient journey and employing a ...
(Date:7/11/2014)... , July 11, 2014 Research and ... "Global and Chinese Medical X-ray Film Industry Report 2014" ... http://photos.prnewswire.com/prnh/20130307/600769 Global And Chinese Medical ... in-depth study on the current state of the Global ... Chinese situation. The report provides a basic overview ...
(Date:7/11/2014)... 2014  Kindred Hospital Houston Northwest, with Wound ... of its new outpatient wound healing center.  The ... with chronic, hard to heal wounds. Chronic wounds ... amputation, lower leg wounds related to blood flow ... traumatic injury wounds which are complex and demonstrate ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Global and Chinese Medical X-ray Film Industry Report 2014 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2
... Mass. , Feb. 4 Recognizing that corporate ... they contain, Northern Light ( www.northernlight.com ) today announced that ... excess of $2 billion can be searched, analyzed ... been steadily increasing the number of market research sources integrated ...
... N.C. , Feb. 4 Gorbec Pharmaceutical ... prescription pharmaceutical products, is opening a GMP-compliant analytical laboratory ... expand Gorbec,s current services for analytical method development and ... its U.S. customer base as well as develop a ...
Cached Medicine Technology:Northern Light Surpasses $2 Billion Worth of Research Content Integrated Into SinglePoint Strategic Research Portals 2Northern Light Surpasses $2 Billion Worth of Research Content Integrated Into SinglePoint Strategic Research Portals 3Gorbec Pharmaceutical Services, Inc. Announces the Launch of Its GMP Analytical Laboratory in China 2
(Date:7/13/2014)... 2014 ECS is being ... a parent of a special needs child, I have ... Seattle community for contemporary special education resources and evidence-based ... to students and families in the Seattle metro area ... for special education. We welcome the opportunity to serve ...
(Date:7/13/2014)... According to The Peripheral Neuropathy Program review recently ... teaches people how to deal with diabetic nerve pain ... program also provides people with safe and effective remedies ... numbness, prickling, burning, and intense stabbing pains. , ... program can help people eliminate some types of pain ...
(Date:7/12/2014)... According to the new market research report ... and Naval Systems) - Global Forecasts and Analysis to ... Radar market are estimated to be $6.08 billion in ... 5.97% to reach $8.61 billion by 2020. , Browse ... spread through 161 pages and in-depth TOC on "Security ...
(Date:7/12/2014)... July 12, 2014 The Chicken ... the past five years, buoyed by stable demand for ... management system. “Eggs are a relatively affordable staple for ... egg consumption generally grows in line with the size ... McKitterick. Furthermore, demand for new specialty egg products with ...
(Date:7/12/2014)... The rise in the number of mobility ... network architectures to suit the upsurge. Virtualization has become ... cloud storage technologies. The data traffic has increased by ... This has resulted in larger and more complex networks. ... the SDN market. , The North American (NA) region ...
Breaking Medicine News(10 mins):Health News:New Private School, Emerald City School, Founded in Downtown Seattle Now Accepting 1st to 6th Grade Students Who Learn Differently 2Health News:The Peripheral Neuropathy Program Review Exposes Randall Labrum's Peripheral Neuropathy Treatment Program – Vkool.com 2Health News:The Peripheral Neuropathy Program Review Exposes Randall Labrum's Peripheral Neuropathy Treatment Program – Vkool.com 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 5
... mortality risk, study suggests , MONDAY, Aug. 17 (HealthDay ... the risk of death among people with peripheral arterial ... when plaque accumulates in arteries that supply blood to ... brain. , The study included 184 PAD patients, average ...
... new report finds no risk from common vitamin and mineral ... E and other antioxidants do not increase the risk for ... study found. , A recent study had suggested that the ... supplemental vitamins C and E, beta carotene, selenium and zinc. ...
... , ALBANY, N.Y., Aug. 17 The New ... 18, 2009, will be an Air Quality Action Day, a ... individuals, such as children, seniors and people with asthma and ... particulate matter and ground-level ozone pollution. The alert is issued ...
... HUDSON, Mass., Aug. 17 Hypertronics ... business and world-leading provider of high performance interconnect solutions for ... circular connectors were selected by Biosense Webster, Inc. for its ... chosen for its optimal signal reliability and ease of use ...
... red wine are thought to help prevent Alzheimer,s disease, and ... Medicine has shown that some of those compounds in fact ... of food science; Connie Weaver, Purdue,s head of foods and ... and nutrition, found that the amount of polyphenols from grapeseed ...
... 17 Wyeth (NYSE: WYE ) (the "Company") announced ... of its outstanding Wyeth Floating Rate Convertible Senior Debentures due 2024 ... 14, 2009, there was $22,664,000 in aggregate principal amount of Convertible ... redeemed by the Company at a cash purchase price of $1,000 ...
Cached Medicine News:Health News:Worries May Worsen Peripheral Arterial Disease 2Health News:Antioxidants Pose No Melanoma Threat 2Health News:Antioxidants Pose No Melanoma Threat 3Health News:Air Quality Action Day Declared for Tuesday, August 18, 2009 2Health News:Hypertronics Circular HyperGrip(R) Connectors Selected for Biosense Webster's CARTO(R) 3 Navigation System 2Health News:Study shows how to boost value of Alzheimer's-fighting compounds 2Health News:Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 2Health News:Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 3Health News:Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 4
With MediLive MindStream you can make, cut and edit digital videos, add commentaries and notes, and save them. MediLive MindStream - intuitive user interface and high-resolution monitor all in one....
... The VISUPAC system and the FF 450plus ... a unique level of accuracy and security ... or aftermarket configuration. Without this level of ... be assured.,Matching the VISUPAC system pixel for ...
... Monitor is the smartest, toughest and most ... an on-board artificial intelligence algorithm, DiogenesTM, the ... arrhythmias while on the patient. The Decipher ... all the rigorous tests required to monitor ...
... The Epicardia 4000 is a hospital-grade ... Epicardia software, Diogenes Arrhythmia and ST analysis ... supporting hardware and software. Facilities with an ... over running reports, customizing them to suit ...
Medicine Products: